DOCSLIB.ORG

Anabolic Steroid Use, Misuse and Addiction

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Anabolic Steroid Use, Misuse and Addiction Anabolic Steroid Use, Misuse And Addiction Introduction Anabolic steroids have an important role to play in the treatment of medical conditions. There is, however, an illicit use of anabolic steroids. Today, most athletes, involved in sports activities that require greater strength, take anabolic steroids to increase their weight and strength. These sports include competitive sports like weight lifting, wrestling, and other strength based contests. In addition, people who are obsessed about having a “perfect” physical appearance also misuse anabolic steroids. The number of individuals using anabolic steroids for sports or to improve their looks is growing. This increased use of anabolic steroids is driven by the perception that they may give a person an edge when it comes to sports activities. Unfortunately, many individuals use anabolic steroids without regard for the disastrous impacts it can have on their bodies. Anabolic Steroids And Testosterone: An Overview Anabolic steroids are an androgenic hormone, and is also known by its proper name anabolic-androgen steroids (AAS). Testosterone is a natural anabolic steroid and it is the primary sex hormone in males. In order to understand anabolic steroids, it is important to know how testosterone works. Testosterone is vital for the development of reproductive organs like the prostate and testes. It enhances male sexual features such as increased bone mass, muscles and body hair growth.1 Testosterone also promotes health and overall wellbeing. For example, it helps ce4less.com ce4less.com ce4less.com ce4less.com ce4less.com 1 prevent osteoporosis. Many abnormalities in the body, such as bone loss or frailty, are associated with testosterone deficiency.2 Synthetic anabolic steroids are an artificial form of the male hormone testosterone. The two major impacts they have on the body are 1) an anabolic impact (the muscle building effect), and 2) an androgenic impact (the masculinizing effect).3 Anabolic steroids differ from corticosteroids such as prednisolone and cortisone. Corticosteroids do not deliver masculinizing or muscle building results. These corticosteroids are prescribed for asthma patients and people having skin problems. They are often medically prescribed as anti-inflammatories.4 Testosterone Formation and Impact Testosterone is produced by the adrenal glands, testes, placenta and ovaries. It is made from cholesterol through a complicated process that takes place in the steroid-producing glands. The total testosterone production in an adult male is around 7 milligrams per day.5 The stimulus for the formation of testosterone arises in the brain, specifically in the hypothalamus. The hypothalamus is a part of the brain where various hormones are produced. These hormones are linked to the function of other glands. For example, the hypothalamus secretes Gonadotrophin Releasing Hormone (GnRH), which is sent to the pituitary gland by special veins called the portal system. Once transmitted, the pituitary gland forms Luteinizing Hormone (LH). Luteinizing Hormone is then released into the blood.6 This hormone is sent to the testis, which is the gland where Leydig cells produce testosterone from stored cholesterol. ce4less.com ce4less.com ce4less.com ce4less.com ce4less.com 2 The feedback mechanism in the pituitary gland controls the rate of hormone production and it is regulated by the blood level of testosterone. With an increase in this level, the secretion of GnRH and LH hormone is reduced or may stop completely. This results in a decline in hormone production. If the opposite happens, i.e., if testosterone blood levels fall, then pituitary secretion is enhanced. In this way, the body maintains an equilibrium in hormone levels. Mode of Mechanism After the formation and secretion of testosterone into the blood stream, a greater percentage of the hormone is tied to protein as it is sent throughout the body. Only the untied or free-state testosterone is biologically active.5 The free-state testosterone in the blood makes up around 1 to 3 percent of the total amount of hormone found in circulation so only 1 to 3 percent of the testosterone level in the blood can interact with tissue receptors. Testosterone’s half-life (the time it takes for half of a substance to degrade or decay) is around 10 minutes. Once testosterone reaches the cell, it is turned into 5 alpha di-hydrotestosterone (DHT). The hormone is then bound to androgen receptors (AR) present in the cells. Finally, it is transported into the nucleus where critical muscle building reactions take place.7 Receptors for injectable or oral steroids works in the same manner. The actual protein production is based on the cell where the reaction takes place. Hence, a muscle cell may only produce muscle protein, irrespective of the kind of anabolic steroid used. After the formation of this complex material, it is then sent to the nucleus activating the ce4less.com ce4less.com ce4less.com ce4less.com ce4less.com 3 genes to form the appropriate proteins. These proteins are released into the cytoplasm of the cell to carry out their function. The features of the specific cell impact the response; for example, muscle cells only make muscle proteins and prostate cells are only able to form prostate protein due to steroid use. Variations in different drugs occur because of the impact of excess substances being freed into the bloodstream. Excess substances impact other organs like the brain. This may lead to abnormal emotional reactions.8 There is a limited number of receptors in a cell. Once the receptors are saturated, they are unable to combine with additional material, therefore limiting the anabolic impact of excessive doses and extended courses. This is called the refractory stage. Studies reveal that some steroids might bind to several receptors at a time. The most common receptor is the glucocorticoid receptor, where steroids replace cortisone. Corticosteroids impact the brain by breaking down tissues, and any hindrance in this activity is helpful for body building.9 Once the steroid course ends, the reverse action is initiated and an increase in catabolism results because of corticosteroids being used by the receptors again. This might be one of the reasons behind the weight loss experienced by some steroid users at the end of their course. After the metabolization of steroid in the nucleus, it is taken from the cell and degraded in the liver, where it is excreted in the urine or bile. The excreted byproducts differ from one androgen to another. These products are identified in sports through drug testing. The liver uses ce4less.com ce4less.com ce4less.com ce4less.com ce4less.com 4 testosterone fast, making it powerless as an oral anabolic agent until it is tied with another radical. For testosterone to be used orally, a chemical group is included with the molecule to enable its absorption in the stomach and to pass through the liver.10 This leads to an increased time frame of the testosterone action enabling more active substance to be in contact with the muscle cells. Impact of Testosterone Testosterone is vital for the development of external genitalia prior to birth and for the formation of sexual differentiation. These are the androgenic impacts of testosterone. In the puberty stage, it causes growth of masculine features like the deepening of the voice, muscularity, development of hair and secondary sexual characteristics. Testosterone secretion is increased in puberty leading to lightening of long bones and finally their closure of epiphyses. It also enhances the sebaceous glands secretions. The other major impact of testosterone is anabolic and the enhanced muscle growth that results.11 This muscle growth is the major attraction for athletes. All steroids hold androgenic and anabolic actions and the review of the chemical structure of widely used anabolic steroids shows these similarities. How do Anabolic Steroids Work? The following diagram explains how steroids work, starting with brain signals to produce testosterone that is eventually released into the bloodstream where they attach to certain cell receptors and function to regulate the production of testosterone.12 ce4less.com ce4less.com ce4less.com ce4less.com ce4less.com 5 The brain transmits chemical signals to the testes, intriguing them to form testosterone. The testes produce testosterone, which is then released into the bloodstream. Once they are the part of the bloodstream, anabolic steroids function like natural testosterone, to a great extent, adding to that which is already formed by testes. Testosterones are attached to MUSCLE cells, which boost growth. Testosterones are attached to receptors in different cells causing varied effects in the body. The brain identifies the levels of testosterone in the blood via a feedback mechanism and controls the amount produced. Anabolic Steroid Drug Prescribing And Use When anabolic steroids are prescribed for a person to use, he or she must have a full understanding of its positive and negative effects. For the non-medical user, the expectations may be unrealistic. Every person has different genetic structure. Diet regulation, stress, training and illness determine the body’s response to anabolic steroids. Steroids are usually given in cycles and are taken in stacks. Stacking implies a practice of using various drugs simultaneously. Stacking is ce4less.com ce4less.com ce4less.com ce4less.com ce4less.com 6 common among steroid users and can also include the use of other drugs besides steroids. Cycling refers to a steroid usage pattern, where drugs are being taken in cycles of a period for weeks followed by a drug free tenure. A key factor is the number and spread of androgen receptors in the muscles.13 There is no exact pattern of distribution of receptors but a majority of people have a greater concentration in their upper body, leading to a greater response in the arms than in the legs. The number slightly increases with the growth of muscle and this might be the reason why some athletes face greater pains with later courses.
Load more

Recommended publications
  • Anabolic Steroid Use Misuse and Addiction
    Anabolic Steroid Use, Misuse And Addiction JASSIN M. JOURIA Dr. Jassin M. Jouria is a medical doctor, professor of academic medicine, and medical author. He graduated from Ross University School of Medicine and has completed his clinical clerkship training in various teaching hospitals throughout New York, including King’s County Hospital Center and Brookdale Medical Center, among others. Dr. Jouria has passed all USMLE medical board exams, and has served as a test prep tutor and instructor for Kaplan. He has developed several medical courses and curricula for a variety of educational institutions. Dr. Jouria has also served on multiple levels in the academic field including faculty member and Department Chair. Dr. Jouria continues to serve as a Subject Matter Expert for several continuing education organizations covering multiple basic medical sciences. He has also developed several continuing medical education courses covering various topics in clinical medicine. Recently, Dr. Jouria has been contracted by the University of Miami/Jackson Memorial Hospital’s Department of Surgery to develop an e-module training series for trauma patient management. Dr. Jouria is currently authoring an academic textbook on Human Anatomy & Physiology. ABSTRACT The synthetic versions of the male hormone testosterone, also known as anabolic steroids, can play an important role in the treatment of health conditions when used as prescribed by a medical clinician. However, misuse of anabolic steroids occurs when these substances are used solely to improve physical appearance or performance. Because there are some potentially serious physical effects of anabolic steroid use, it is important that anabolic steroids are only used as prescribed and always under a medical clinician’s guidance.
    [Show full text]
  • Progestin-Only Systemic Hormone Therapy for Menopausal Hot Flashes
    EDITORIAL Progestin-only systemic hormone therapy for menopausal hot flashes Clinicians treating postmenopausal hot flashes often recommend “systemic estrogen treatment.” However, progestin-only therapy also can effectively treat hot flashes and is an option for women with a contraindication to estrogen therapy. Robert L. Barbieri, MD Editor in Chief, OBG MANAGEMENT Chair, Obstetrics and Gynecology Brigham and Women’s Hospital Boston, Massachusetts Kate Macy Ladd Professor of Obstetrics, Gynecology and Reproductive Biology Harvard Medical School he field of menopause medi- women. In one study, 133 postmeno- in postmenopausal women with cine is dominated by studies pausal women with an average age an American Heart Association risk T documenting the effective- of 55 years and approximately 3 years score greater than 10% over 10 years.3 ness of systemic estrogen or estro- from their last menstrual period were Additional contraindications to sys- gen-progestin hormone therapy for randomly assigned to 12 weeks of temic estrogen include women with the treatment of hot flashes caused treatment with placebo or micronized cardiac disease who have a throm- by hypoestrogenism. The effective- progesterone 300 mg daily taken at bophilia, such as the Factor V Leiden ness of progestin-only systemic bedtime.1 Mean serum progesterone mutation.4 hormone therapy for the treatment levels were 0.28 ng/mL (0.89 nM) and For women who are at high risk of hot flashes is much less studied 27 ng/mL (86 nM) in the women taking for estrogen-induced cardiovascu- and seldom is utilized in clinical placebo and micronized progesterone, lar events, micronized progesterone practice.
    [Show full text]
  • New Rules Pertaining to the Banning of Anabolic Steroids in the Western Australian Harness Racing Industry to Be Introduced 1St September 2014
    NEW RULES PERTAINING TO THE BANNING OF ANABOLIC STEROIDS IN THE WESTERN AUSTRALIAN HARNESS RACING INDUSTRY TO BE INTRODUCED 1ST SEPTEMBER 2014 Notice is hereby given that the Board of Racing and Wagering WA have resolved that the RWWA Rules of Harness Racing 2004 be amended. In accordance with section 45 (1) (b) of the Racing and Wagering Western Australia Act 2003 the Board of Racing and Wagering WA on the 10th April 2014 resolved that these amendments be adopted accordingly into the RWWA Rules of Harness Racing. The Harness Racing Board had advised of these amendments and the RWWA Board has determined that these amendments will come into effect on 1st September 2014. The details of the relevant rules pertaining to this ban of anabolic steroids for reference can be found following this advice. There are many implications arising from the introduction of these rules, and to assist trainers and veterinarians to comply with the new rules the following explanatory statement has been prepared. Which steroids are banned under these rules? The new rules ban the use of "anabolic androgenic steroids" in Standardbred horses at any time from birth until retirement. "Anabolic androgenic steroids" include those that are currently registered in Australia by the APVMA for use in horses, such as boldenone, ethylestrenol (in Nitrotain), methandriol, nandrolone, stanozolol and testosterone. Exogenous anabolic androgenic steroids that are banned also include but are not limited to those listed in the WADA prohibited list, such as 1-androstenediol; 1-androstenedione;
    [Show full text]
  • Informed Consent for Feminizing Hormone Therapy
    Informed Consent for Feminizing Hormone Therapy For _________________________ Date of Birth: _____________ Name Used: ____________________ Patient Name as listed in chart Name if different from chart This form will assist you (and your guardian) to think through the expected effects of hormone therapy including possible unwanted side effects. You are encouraged to talk about this treatment with your medical provider and decide if hormone therapy is right for you (your child). By signing this form, you are stating that you have discussed the effects and risks of this medication with your medical provider or a member of the medical team and that you understand and accept these effects and possible risks. You (and your guardian) may ask questions and talk about any concerns you have related to this treatment at any time in this process. Estrogen (usually estradiol) is used to feminize the body (make it look more traditionally female). This medical treatment will reduce some male features and increase some female features of the body. Androgen (testosterone) blockers further decrease the amount of and/or block the effect of testosterone and masculinization of the body. Your medical provider will help decide which form and the amount of estrogen (shots, pills, gels, patches) and androgen blockers (pills, gels, shots, implanted) that are best for you based on your personal needs and any medical or mental health conditions you might have. Each person’s body responds to estrogen differently and it is hard to promise or predict with certainty how each person may respond to treatment. Your medical provider will talk with you throughout the treatment and will help you achieve the best results safely.
    [Show full text]
  • A Guide to Feminizing Hormones – Estrogen
    1 | Feminizing Hormones ​ ​ A Guide to Feminizing Hormones Hormone therapy is an option that can help transgender and gender-diverse people feel more comfortable in their bodies. Like other medical treatments, there are benefits and risks. Knowing what to expect will help us work together to maximize the benefits and minimize the risks. What are hormones? Hormones are chemical messengers that tell the body’s cells how to function, ​ when to grow, when to divide, and when to die. They regulate many functions, including growth, sex drive, hunger, thirst, digestion, metabolism, fat burning & storage, blood sugar, cholesterol levels, and reproduction. What are sex hormones? Sex hormones regulate the development of sex characteristics, including the sex ​ organs such as genitals and ovaries/testicles. Sex hormones also affect the secondary sex characteristics that typically develop at puberty, like facial and body hair, bone growth, breast growth, and voice changes. There are three categories of sex hormones in the body: • Androgens: testosterone, dehydroepiandrosterone (DHEA), ​ dihydrotestosterone (DHT) • Estrogens: estradiol, estriol, estrone ​ • Progestin: progesterone ​ Generally, “males” tend to have higher androgen levels, and “females” tend to have higher levels of estrogens and progestogens. What is hormone therapy? Hormone therapy is taking medicine to change the levels of sex hormones in your body. Changing these levels will affect your hair growth, voice pitch, fat distribution, muscle mass, and other features associated with sex and gender. Feminizing hormone therapy can help make the body look and feel less “masculine” and more “feminine" — making your body more closely match your identity. What medicines are involved? There are different kinds of medicines used to change the levels of sex hormones in your body.
    [Show full text]
  • Download Product Insert (PDF)
    Product Information Boldenone Cypionate Item No. 15158 CAS Registry No.: 106505-90-2 O Formal Name: 17β-hydroxy-androsta-1,4-dien-3-one O cyclopentanepropionate MF: C27H38O3 FW: 410.6 H Purity: ≥95% Stability: ≥2 years at -20°C H H Supplied as: A crystalline solid λ O UV/Vis.: max: 244 nm Laboratory Procedures For long term storage, we suggest that boldenone cypionate be stored as supplied at -20°C. It should be stable for at least two years. Boldenone cypionate is supplied as a crystalline solid. A stock solution may be made by dissolving the boldenone cypionate in the solvent of choice. Boldenone cypionate is soluble in organic solvents such as ethanol, DMSO, and dimethyl formamide, which should be purged with an inert gas. The solubility of boldenone cypionate in these solvents is approximately 15, 5, and 25 mg/ml, respectively. Boldenone cypionate is sparingly soluble in aqueous buffers. For maximum solubility in aqueous buffers, boldenone cypionate should first be dissolved in ethanol and then diluted with the aqueous buffer of choice. Boldenone cypionate has a solubility of approximately 0.3 mg/ml in a 1:2 solution of ethanol:PBS (pH 7.2) using this method. We do not recommend storing the aqueous solution for more than one day. Boldenone is an anabolic androgenic steroid and synthetic derivative of testosterone that was originally developed for veterinary use.1 It can increase nitrogen retention, protein synthesis, and appetite, and also stimulates the release of erythropoietin in the kidneys.1 Boldenone cypionate was synthesized as an ester of boldenone in an attempt to alter boldenone’s very long half-life.2 Anabolic androgenic steroid compounds such as boldenone cypionate have been used illicitly by bodybuilders and other athletes.3 This compound is intended for forensic and research purposes only.
    [Show full text]
  • Ranvet's Filybol
    Ranvet's Filybol Ranvet Chemwatch Hazard Alert Code: 2 Chemwatch: 4787-83 Issue Date: 08/02/2016 Version No: 5.1.1.1 Print Date: 10/28/2016 Safety Data Sheet according to WHS and ADG requirements S.GHS.AUS.EN SECTION 1 IDENTIFICATION OF THE SUBSTANCE / MIXTURE AND OF THE COMPANY / UNDERTAKING Product Identifier Product name Ranvet's Filybol Chemical Name peanut oil Synonyms Not Available Other means of Not Available identification Relevant identified uses of the substance or mixture and uses advised against Relevant identified Non-virilising anabolic combination for fillies, mares, colts and stallions. uses Details of the supplier of the safety data sheet Registered company Ranvet name Address 10-12 Green Street Banksmeadow NSW 2019 Australia Telephone +61 2 9666 1744 Fax +61 2 9666 1755 Website https://www.ranvet.com.au/other_msds.htm Email [email protected] Emergency telephone number Association / Not Available Organisation Emergency telephone +61 425 061 584 numbers Other emergency Not Available telephone numbers SECTION 2 HAZARDS IDENTIFICATION Classification of the substance or mixture Poisons Schedule S4 Carcinogenicity Category 2, Reproductive Toxicity Category 2, Acute Aquatic Hazard Category 2, Chronic Aquatic Hazard Classification [1] Category 2 1. Classified by Chemwatch; 2. Classification drawn from HSIS ; 3. Classification drawn from EC Directive 1272/2008 - Annex Legend: VI Label elements GHS label elements SIGNAL WORD WARNING Continued... Chemwatch: 4787-83 Page 2 of 10 Issue Date: 08/02/2016 Version No: 5.1.1.1 Ranvet's Filybol Print Date: 10/28/2016 Hazard statement(s) H351 Suspected of causing cancer. H361 Suspected of damaging fertility or the unborn child.
    [Show full text]
  • Effects of Androgenic-Anabolic Steroids on Apolipoproteins and Lipoprotein (A) F Hartgens, G Rietjens, H a Keizer, H Kuipers, B H R Wolffenbuttel
    253 Br J Sports Med: first published as 10.1136/bjsm.2003.000199 on 21 May 2004. Downloaded from ORIGINAL ARTICLE Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a) F Hartgens, G Rietjens, H A Keizer, H Kuipers, B H R Wolffenbuttel ............................................................................................................................... Br J Sports Med 2004;38:253–259. doi: 10.1136/bjsm.2003.000199 Objectives: To investigate the effects of two different regimens of androgenic-anabolic steroid (AAS) administration on serum lipid and lipoproteins, and recovery of these variables after drug cessation, as indicators of the risk for cardiovascular disease in healthy male strength athletes. Methods: In a non-blinded study (study 1) serum lipoproteins and lipids were assessed in 19 subjects who self administered AASs for eight or 14 weeks, and in 16 non-using volunteers. In a randomised double blind, placebo controlled design, the effects of intramuscular administration of nandrolone decanoate (200 mg/week) for eight weeks on the same variables in 16 bodybuilders were studied (study 2). Fasting serum concentrations of total cholesterol, triglycerides, HDL-cholesterol (HDL-C), HDL2-cholesterol (HDL2- C), HDL3-cholesterol (HDL3-C), apolipoprotein A1 (Apo-A1), apolipoprotein B (Apo-B), and lipoprotein (a) (Lp(a)) were determined. Results: In study 1 AAS administration led to decreases in serum concentrations of HDL-C (from 1.08 (0.30) to 0.43 (0.22) mmol/l), HDL2-C (from 0.21 (0.18) to 0.05 (0.03) mmol/l), HDL3-C (from 0.87 (0.24) to 0.40 (0.20) mmol/l, and Apo-A1 (from 1.41 (0.27) to 0.71 (0.34) g/l), whereas Apo-B increased from 0.96 (0.13) to 1.32 (0.28) g/l.
    [Show full text]
  • Metabolism of Anabolic Steroids in Man: Synthesis and Use of Reference Substances for Identification of Anabolic Steroid Metabolites
    Anaiytzca Chumca Acta, 275 (1993) 23-48 23 Elsevler hence Publishers B V , Amsterdam Metabolism of anabolic steroids in man: synthesis and use of reference substances for identification of anabolic steroid metabolites Will1 Schanxer and Manfred Domke LkutscheS’rthochschuk Koln, Inrhtut f?u Bwchemre, Carl-L&m-Weg 4 5ooO Cologne 41 (Germuny) (Recewed 20th May 1992) AhStl-& The use of anabohc steroids was banned by the International Olympic Comnuttee for the first tune at the Olympic Games m Montreal m 1976 Since that tie the nususe of anabohc steroxls by athletes has been controlled by analysis of urme extracts by gas chromatography-mass spectrometry @C-MS) The excreted steroids or their metabohtes, or both, are isolated from urme by XAD-2 adsorption, enzymatx hydrolyss of coqlugated excreted metabobtes anth /?-glucuromdase from Es&en&u co& bqmd-bqmd extractlon mth diethyl ether, and courted mto tnmethylsdyl (‘INiS) derwatwes The confirmation of an anabobc stenxd nususe ts based on comparison of the electron nnpact lomzation (EI) mass spectrum and GC retention tie of the isolated steroid and/or its metabohte with the El mass spectrum and GC retention time of authentic reference substances For this purpose excretion studies with the most common anabobc steroids were performed and the mam excreted metabobtes were synthesued for bolasterone, boldenone, 4-chiorodehydromethyltestosterone, clostebol, drostanolone, tluoxymesterone, forme- bolone, me&a&one, mesterolone, metandlenone, methandnol, metenolone, methyltestosterone, nandrolone, norethandrolone,
    [Show full text]
  • Megestrol Acetate/Melengestrol Acetate 2115 Adverse Effects and Precautions Megestrol Acetate Is Also Used in the Treatment of Ano- 16
    Megestrol Acetate/Melengestrol Acetate 2115 Adverse Effects and Precautions Megestrol acetate is also used in the treatment of ano- 16. Mwamburi DM, et al. Comparing megestrol acetate therapy with oxandrolone therapy for HIV-related weight loss: similar As for progestogens in general (see Progesterone, rexia and cachexia (see below) in patients with cancer results in 2 months. Clin Infect Dis 2004; 38: 895–902. p.2125). The weight gain that may occur with meges- or AIDS. The usual dose is 400 to 800 mg daily, as tab- 17. Grunfeld C, et al. Oxandrolone in the treatment of HIV-associ- ated weight loss in men: a randomized, double-blind, placebo- trol acetate appears to be associated with an increased lets or oral suspension. A suspension of megestrol ace- controlled study. J Acquir Immune Defic Syndr 2006; 41: appetite and food intake rather than with fluid reten- tate that has an increased bioavailability is also availa- 304–14. tion. Megestrol acetate may have glucocorticoid ef- ble (Megace ES; Par Pharmaceutical, USA) and is Hot flushes. Megestrol has been used to treat hot flushes in fects when given long term. given in a dose of 625 mg in 5 mL daily for anorexia, women with breast cancer (to avoid the potentially tumour-stim- cachexia, or unexplained significant weight loss in pa- ulating effects of an oestrogen—see Malignant Neoplasms, un- Effects on carbohydrate metabolism. Megestrol therapy der Precautions of HRT, p.2075), as well as in men with hot 1-3 4 tients with AIDS. has been associated with hyperglycaemia or diabetes mellitus flushes after orchidectomy or anti-androgen therapy for prostate in AIDS patients being treated for cachexia.
    [Show full text]
  • Part I Biopharmaceuticals
    1 Part I Biopharmaceuticals Translational Medicine: Molecular Pharmacology and Drug Discovery First Edition. Edited by Robert A. Meyers. © 2018 Wiley-VCH Verlag GmbH & Co. KGaA. Published 2018 by Wiley-VCH Verlag GmbH & Co. KGaA. 3 1 Analogs and Antagonists of Male Sex Hormones Robert W. Brueggemeier The Ohio State University, Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Columbus, Ohio 43210, USA 1Introduction6 2 Historical 6 3 Endogenous Male Sex Hormones 7 3.1 Occurrence and Physiological Roles 7 3.2 Biosynthesis 8 3.3 Absorption and Distribution 12 3.4 Metabolism 13 3.4.1 Reductive Metabolism 14 3.4.2 Oxidative Metabolism 17 3.5 Mechanism of Action 19 4 Synthetic Androgens 24 4.1 Current Drugs on the Market 24 4.2 Therapeutic Uses and Bioassays 25 4.3 Structure–Activity Relationships for Steroidal Androgens 26 4.3.1 Early Modifications 26 4.3.2 Methylated Derivatives 26 4.3.3 Ester Derivatives 27 4.3.4 Halo Derivatives 27 4.3.5 Other Androgen Derivatives 28 4.3.6 Summary of Structure–Activity Relationships of Steroidal Androgens 28 4.4 Nonsteroidal Androgens, Selective Androgen Receptor Modulators (SARMs) 30 4.5 Absorption, Distribution, and Metabolism 31 4.6 Toxicities 32 Translational Medicine: Molecular Pharmacology and Drug Discovery First Edition. Edited by Robert A. Meyers. © 2018 Wiley-VCH Verlag GmbH & Co. KGaA. Published 2018 by Wiley-VCH Verlag GmbH & Co. KGaA. 4 Analogs and Antagonists of Male Sex Hormones 5 Anabolic Agents 32 5.1 Current Drugs on the Market 32 5.2 Therapeutic Uses and Bioassays
    [Show full text]
  • New Zealand Data Sheet 1. Product Name
    NEW ZEALAND DATA SHEET 1. PRODUCT NAME SUSTANON 250 (250 mg testosterone esters solution for injection) (SUSTANON) TESTOSTERONE ESTERS 250mg/mL for injection Presentations that are not currently available The vials are currently not available 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Name and strength of the active substances - testosterone proprionate 30mg testosterone phenylpropionate 60mg testosterone isocaproate 60mg testosterone decanoate 100mg All four compounds are esters of the natural hormone testosterone. The total amount of testosterone per 1 mL is 176mg. List of excipients - 1 mL arachis oil and the solution also contains 10 per cent benzyl alcohol. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Oily solution for intramuscular use. A clear, pale yellow solution. Each clear glass ampoule or vial contains 1 mL in arachis oil. 4. CLINICAL PARTICULARS 4.1 Therapeutic indications Testosterone replacement therapy in males for conditions associated with primary and secondary hypogonadism, either congenital or acquired. In female to male transsexuals: • masculinization Moreover, in men testosterone therapy may be indicated in osteoporosis caused by androgen deficiency. 4.2 Dose and method of administration In general, the dose should be adjusted according to the response of the individual patient. Dose Adults (incl. elderly): Usually, one injection of 1ml per three weeks is adequate. Paediatric population: Safety and efficacy in children and adolescents, have not yet been established. Pre-pubertal children treated with SUSTANON should be treated with caution (see Warnings and Precautions). SUSTANON contains benzyl alcohol and is contraindicatedin children under 3 years of age. Method of administration SUSTANON should be administered by deep intramuscular injection.
    [Show full text]